Targeting MDM2–p53 Axis through Drug Repurposing for Cancer Therapy: A Multidisciplinary Approach
ACS Omega · 26.09.2023 · 8 (38) · 34583-34596
DOI: 10.1021/acsomega.3c03471 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 15.09.2023. Verfasst von Naeem Abdul Ghafoor und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Graduate School of Natural and Applied Sciences, Mugla Sitki Kocman University, 48000 Mugla, Turkey. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Support and Funding Office, Mugla Sitki Ko?man University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Molecular Biology and Genetics, Graduate School of Natural and Applied Sciences, Mugla Sitki Kocman University, 48000 Mugla, Turkey.
- Department of Molecular Biology and Genetics, Faculty of Science, Mugla Sitki Kocman University, 48000 Mugla, Turkey.
ORCID-Profile: Aysegul Yildiz
Förderung
- Research Support and Funding Office, Mugla Sitki Ko?man University
Zitieren
APA
Ghafoor, N. A., & Yildiz, A. (2023). Targeting MDM2–p53 Axis through Drug Repurposing for Cancer Therapy: A Multidisciplinary Approach. ACS Omega, 8(38), 34583-34596. https://doi.org/10.1021/acsomega.3c03471
Vancouver
Ghafoor NA, Yildiz A. Targeting MDM2–p53 Axis through Drug Repurposing for Cancer Therapy: A Multidisciplinary Approach. ACS Omega. 2023;8(38):34583-34596. doi:10.1021/acsomega.3c03471
BibTeX
@article{Ghafoor2023,
author = {Ghafoor, Naeem Abdul and Yildiz, Aysegul},
title = {Targeting MDM2–p53 Axis through Drug Repurposing for Cancer Therapy: A Multidisciplinary Approach},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {38},
pages = {34583--34596},
doi = {10.1021/acsomega.3c03471}
}
EUVIMED